Semaglutide injections function as a GLP-1 receptor agonist that works systemically in your bloodstream, not in your digestive tract, making meal timing less critical than with oral medications
MuRF1 and atrogin-1 are E3 ubiquitin ligases that act as key effectors of the ubiquitinproteasome degradation pathway
Watch this space for an upcoming blog post about the strategies employers can take to manage the GLP-1 trend
Discussing GLP-1 Treatment Options With Your Healthcare Team If you have Crohn's disease and are considering GLP-1 medication whether for type 2 diabetes management or weight lossit is essential to have an open, detailed conversation with your healthcare team
By strengthening healthcare systems, these partnerships aim to help ensure that breakthrough therapies can be effectively delivered to underserved populations, translating innovation into real-world impact
A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing